Skip to content

Advertisement

Open Peer Review Reports for: Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
2 Apr 2017 Submitted Original manuscript
8 Aug 2017 Reviewed Reviewer Report - Katherine Tkaczuk
16 Aug 2017 Reviewed Reviewer Report - Ioannis Voutsadakis
5 Sep 2017 Reviewed Reviewer Report - Bora Lim
8 Oct 2017 Author responded Author comments - Sakura Iizumi
Resubmission - Version 2
8 Oct 2017 Submitted Manuscript version 2
27 Oct 2017 Reviewed Reviewer Report - Bora Lim
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
24 Nov 2017 Editorially accepted
4 Dec 2017 Article published 10.1186/s12885-017-3846-8

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement